本帖最后由 NKU 于 2022-9-14 22:10 编辑
这篇帖子并不能真实地反应南开医学院的论文，偏向于南开大学附属天津市的医院。301医院的论文统计得少，陈香美院士有几篇都不在统计范围。
301医院付小兵院士Bioactive Materials
https://www.sciencedirect.com/science/article/pii/S2452199X22003632
301医院郭全义International Journal of Biological Macromolecules
https://www.sciencedirect.com/sc ... i/S0141813022019936
附属口腔医院跟南开大学多个二级学院都有合作，居然和南开大学人工智能学院（机器人研究所）也合作发表一篇Journal of Dentistry。Journal of Dentistry
https://www.sciencedirect.com/sc ... i/S0300571222003414
南开大学附属口腔医院刘浩院长共同通讯作者Cancer Gene Therapy
南开大学附属口腔医院位通讯作者+并列一作单位
https://www.nature.com/articles/s41417-022-00526-6
Hao Liu
[*]Department of Prosthodontics, Tianjin Stomatological Hospital, Hospital of Stomatology, NanKai University, 300041, Tianjin, China
更新了妇产医院和口腔医院几篇论文
南开大学附属妇产医院更新了医院主页（天津市中心妇产科医院 (tjzxfc.cn)），主页里，已经显示南开大学附属医院字样。
妇产医院官方指定了英文地址：Tianjin Key Laboratory of Human Development and Reproductive Regulation, Tianjin Central Hospital ofObstetrics and Gynecology, Nankai University Maternity Hospital, Tianjin, China.
Cell Transplant. 2022 Jan-Dec;31:9636897221132502. doi: 10.1177/09636897221132502.
A Case of Daratumumab-Induced Significant Decrease in Donor-Specific HLA Antibodies and Remission Induction Before Haploidentical Stem Cell Transplantation in a Refractory B-ALL Patient
Xin Li 1, Haibo Zhu 1, Tao Sui 1, Xingli Zhao 2, Qi Deng 1
Affiliations
1Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
2Departments of Oncology and Hematology, Tianjin People's Hospital, School of Medicine, Nankai University, Tianjin, China.
PMID: 36278404 DOI: 10.1177/09636897221132502
Int J Endocrinol. 2022 Oct 17;2022:8968793. doi: 10.1155/2022/8968793. eCollection 2022.
Establishment and Validation of a New Predictive Model for Insulin Resistance based on 2 Chinese Cohorts: A Cross-Sectional Study
Shi Zhang 1, Xin-Cheng Wang 1 2, Jing Li 1, Xiao-He Wang 3, Yi Wang 1, Yan-Ju Zhang 1, Mei-Yang Du 1, Min-Ying Zhang 2, Jing-Na Lin 1, Chun-Jun Li 1
Affiliations
1Department of Endocrinology, Health Management Center, Tianjin Union Medical Center, Nankai University Affiliated Hospital, Tianjin, China.
2School of Medicine, Nankai University, Tianjin, China.
3Tianjin Centers for Disease Control and Prevention, Tianjin, China.
PMID: 36299856 PMCID: PMC9592226 DOI: 10.1155/2022/8968793
南开大学人民医院，南开大学附属天津市第一中心医院各一篇
Int J Endocrinol. 2022 Oct 17;2022:8968793. doi: 10.1155/2022/8968793. eCollection 2022.
Affiliations
1Department of Endocrinology, Health Management Center, Tianjin Union Medical Center, Nankai University Affiliated Hospital, Tianjin, China.
2School of Medicine, Nankai University, Tianjin, China.
3Tianjin Centers for Disease Control and Prevention, Tianjin, China.
Cell Transplant. 2022 Jan-Dec;31:9636897221132502. doi: 10.1177/09636897221132502.
Affiliations
1Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
2Departments of Oncology and Hematology, Tianjin People's Hospital, School of Medicine, Nankai University, Tianjin, China.
医学院301医院郭全义教授Biomaterials，通讯作者：Zhiguo Yuan，郭全义，Shuyun Liu
Biomaterials, Available online 12 November 2022, In press, journal pre-proof, Article 121888
https://www.sciencedirect.com/science/article/abs/pii/S0142961222005282
本帖最后由 NKU 于 2022-11-13 17:25 编辑
医学院第三中心医院刘辉（硕士生导师）通讯作者Mol Biol Rep，刘辉副研究员主页：https://medical.nankai.edu.cn/2022/0928/c6622a481005/page.htm
Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Nankai University, Tianjin, 300170, China
https://link.springer.com/article/10.1007/s11033-022-08045-1
南开大学附属天津市第一中心医院沈中阳院长，与曹校长（生命科学学院免疫所）合作Signal Transduction and Targeted Therapy，陈筱素博士后为并列一作
https://www.nature.com/articles/s41392-022-01237-y
Affiliations
Frontier Research Center for Cell Response, Institute of Immunology, College of Life Sciences, Nankai University, Tianjin, 300071, China 南开大学免疫学研究所
Organ Transplant Center, Tianjin First Central Hospital, Nankai University, Tianjin, 300192, China南开大学附属天津市第一中心医院
南开大学人民医院一篇PNAS，通讯作者为王磊副校长。南开在论文和课题方面都远优于附属医院，要带一下。互利。
Escherichia coli O157:H7 senses microbiota-produced riboflavin to increase its virulence in the gut | PNAS
The Institute of Translational Medicine, Tianjin Union Medical Center, Nankai University, Tianjin 300121, People’s Republic of China
在论文发表和课题申请上，南开都应该带一下附属医院，毕竟论文和课题毫无疑问是南开的长处。王磊校长这篇PNAS署名很好（虽然署名仍然不够规范，TUMC无法被快速单独识别出），使得论文既属于人民医院也属于南开大学。
从目前南开医学动向来看，南开医已经逐步回归天津，期待南开和附属医院相互成就吧。不过，无论如何不能放弃和301的深度合作，301每年至少3位院士都是要招南开博士生的。
目前，在nature index上，南开大学人民医院（英文Tianjin Union Medical Centre，TUMC英文翻译回来叫，天津联合医学中心），已经是在南开名下，不过数据实在太感人。https://www.nature.com/nature-index/institution-outputs/china/tianjin-union-medicine-centre/54124506140ba02575e3193a
南开大学附属口腔医院，也在南开名下，同样的论文也很感人。https://www.nature.com/nature-index/institution-outputs/china/tianjin-stomatological-hospital-nku/5e707ed07b7b56691c1ae781
本帖最后由 NKU 于 2022-11-25 21:02 编辑
南开大学人民医院内分泌科主任林静娜主任医师Diabetes/Metabolism Research and Reviews
https://onlinelibrary.wiley.com/doi/10.1002/dmrr.3597
Department of Endocrinology, Health Management Center, Tianjin Union Medical Center, Nankai University, Tianjin, China
林静娜主任为南开医学院内科学博士生导师
NKU 发表于 2022-11-22 21:10
在论文发表和课题申请上，南开都应该带一下附属医院，毕竟论文和课题毫无疑问是南开的长处。王磊校长这 ...
数据感人没关系，学校和医院共同努力 共同提高
本帖最后由 NKU 于 2022-11-26 00:41 编辑
医学院301医院郭全义课题组Acta Pharmaceutica Sinica B
Advancing drug delivery to articular cartilage: from single to multiple strategies - ScienceDirect
医学院人民医院杨荣存Cellular and Molecular Gastroenterology and Hepatology
https://www.sciencedirect.com/sc ... i/S2352345X22002387
附属南开医院Free Radical Biology and Medicine
https://www.sciencedirect.com/sc ... i/S0891584922009959
Department of Anesthesiology and Critical Care Medicine, Tianjin Nankai Hospital, School of Medicine, Nankai University, Tianjin, China